More human studies are necessary to determine its safety profile
But BPC-157 continues gaining momentum in real-world users because it simply works in places where modern rehabilitation medicines don't: slow tendon healing connective tissue recovery chronic inflammatory pain post-surgical fibrosis overuse injuries impaired vascularization gastrointestinal barrier dysfunction recovery bottlenecks in repetitive stress conditions It's quite clear that the regenerative properties of BPC-157, especially when it comes to tissue repair, have only increased the buzz around this peptide
in vivo studies (animal models): It's absolutely paramount to consult existing scientific literature, particularly peer-reviewed articles, specific to your chosen model and research question
It also acts as a lipotropic which converts fats into other useful products
But they are not the same compound, and they do not work through the same Peptide research has grown fast over the past few years, and the BPC-157 vs TB-500 comparison comes up again and again
This dual action makes PanOxyl particularly effective for those who experience both inflammatory and non-inflammatory acne